Nuvation Bio Inc. (NUVB) Profit Margins
Over the twelve months to 2026-06-30, Nuvation Bio Inc. (NUVB) had operating margin -81.0%, net margin -88.2%, free cash flow margin -75.9%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
NUVBNuvation Bio Inc.Follow NUVB — free
—
Price chart with a free account
- Market cap
- 1.6B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|
| Gross margin | 10.1% | — | — | |
| Operating margin | -7527.3% | -338.7% | -81.0% | |
| Net margin | -7213.8% | -325.3% | -88.2% | |
| FCF margin | -1658.5% | -289.0% | -75.9% |
USD millions · SEC XBRL
Nuvation Bio Inc. — questions
- What is Nuvation Bio Inc.'s operating margin?
- -81.0% over the twelve months to 2026-06-30.
- What is Nuvation Bio Inc.'s net profit margin?
- -88.2% over the twelve months to 2026-06-30.
Every figure on this page comes from Nuvation Bio Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.